Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

The Systemic And Local Immune Response To Intranasal Influenza Vaccination

Trial Profile

The Systemic And Local Immune Response To Intranasal Influenza Vaccination

Recruiting
Phase of Trial: Phase II

Latest Information Update: 10 Sep 2018

At a glance

  • Drugs Influenza virus vaccine live (Primary)
  • Indications Influenza virus infections
  • Focus Pharmacodynamics
  • Most Recent Events

    • 24 Oct 2016 Results of a comparative analysis from NCT01003288 and NCT01866540 studies published in the Vaccine.
    • 19 Sep 2016 Planned End Date changed from 1 Dec 2015 to 1 Dec 2017.
    • 19 Sep 2016 Planned primary completion date changed from 1 Dec 2015 to 1 Dec 2017.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top